PDCD1 and cancer: In conclusion, our results suggested that has-circRNA-002178 could be used as a potential non-invasive biomarker for the early detection of LUAD, and function as a ceRNA to enhance PDL1 and PD1 expression in cancer cells and T cells, respectively.